Autopsy report · NCT00696007
Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer
Cause of deathSlow enrollment
“Study was unable to recruit subjects meeting the study requirements.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- Lahey Clinic
- Sponsor type
- University, hospital or other
- Conditions
- Transitional Cell Carcinoma
- Interventions
- Gemcitabine and cisplatin; Retrospective comparison
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- The Effect of Combination Lumacaftor and Ivacaftor on Markers of Hyperglycemia
“We were unable to enroll eligible subjects for the study.” - Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis and Crohn's Disease
“The study was withdrawn due to not being able to recruit subjects.” - A Pilot and Feasibility Study of Fecal Microbiota Transplantation for Ulcerative Colitis
“Unable to recruit and enroll eligible subjects.” - Pilot Study of the Neuro-Spinal Scaffold for the Treatment of AIS A Cervical Acute SCI
“Study did not enroll any subjects.” - Gastric and Autonomic Functions in Patients With Intragastric Balloon
“The study did not recruit any participant.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.